vTv Therapeutics (VTVT) Long-Term Debt Repayments (2014 - 2025)

vTv Therapeutics has disclosed Long-Term Debt Repayments across 11 years of filings, most recently posting $328000.0 for Q4 2025.

• Long-Term Debt Repayments for Q4 2025 came in at $328000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $392000.0 (up 105.24% YoY), and the FY2025 annual result was $392000.0, up 105.24% from the prior year.
• Long-Term Debt Repayments came in at $328000.0 for Q4 2025 at vTv Therapeutics, up from $64000.0 in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $380000.0 in Q4 2021 to a low of $64000.0 in Q3 2025.
• The 5-year median for Long-Term Debt Repayments is $237500.0 (2021), against an average of $225416.7.
• Across the five-year window, Long-Term Debt Repayments plunged 95.36% in 2021 and soared 204.76% in 2022, its largest moves.
• vTv Therapeutics' Long-Term Debt Repayments stood at $380000.0 in 2021, then declined by 12.37% to $333000.0 in 2022, then dropped by 15.32% to $282000.0 in 2023, then slumped by 32.27% to $191000.0 in 2024, then soared by 71.73% to $328000.0 in 2025.
• The last three Long-Term Debt Repayments figures came in at $328000.0 (Q4 2025), $64000.0 (Q3 2025), and $191000.0 (Q1 2024), per Business Quant data.